Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia

Transplant Infectious Disease

Volumn 14, Issue 1, 2012, Pages 79-85

  Uhlenhaut, C ^a   Cohen, J I ^b   Pavletic, S ^c   Illei, G ^d   Gea Banacloche, J C ^c   Abu Asab, M ^c   Krogmann, T ^b   Gubareva, L ^e   Mcclenahan, S ^a   Krause, P R ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^e NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Coronavirus; Generic virus detection; HKU1; Immunocompromised; Viral infections; Virus discovery

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUDARABINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PREDNISONE; RIBAVIRIN; RITUXIMAB; ZANAMIVIR;

ADD ON THERAPY; ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUTOPSY; BRONCHOPNEUMONIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS; CORONAVIRUS HKU1; CORONAVIRUS HKU1 INFECTION; CORONAVIRUS INFECTION; CORTICOSTEROID THERAPY; CUSHINGOID SYNDROME; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DYSPNEA; ELECTRON MICROSCOPY; FEMALE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; HYPOXEMIA; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; LUNG BIOPSY; LUNG INFILTRATE; LUNG LAVAGE; LUPUS ERYTHEMATOSUS NEPHRITIS; NOSE CONGESTION; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHINORRHEA; SYSTEMIC LUPUS ERYTHEMATOSUS; THORACOCENTESIS; VIRUS DETECTION; WHEEZING;

ADULT; AUTOPSY; BIOPSY; CORONAVIRUS; CORONAVIRUS INFECTIONS; FATAL OUTCOME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION;

EID: 84855542880     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00657.x     Document Type: Article

References (21)

1. Nanda S, Jayan G, Voulgaropoulou F, et al. Universal virus detection by degenerate-oligonucleotide primed polymerase chain reaction of purified viral nucleic acids. J Virol Methods 2008; 152(1-2): 18-24.
2. Moscona A. Oseltamivir resistance-disabling our influenza defenses. N Engl J Med 2005; 353(25): 2633-2636.
3. Carr J, Ives J, Kelly L, et al. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Res 2002; 54(2): 79-88.
4. Uhlenhaut C, Cohen JI, Fedorko D, Nanda S, Krause PR. Use of a universal virus detection assay to identify human metapneumovirus in a hematopoietic stem cell transplant recipient with pneumonia of unknown origin. J Clin Virol 2009; 44(4): 337-339.
5. Vabret A, Dina J, Gouarin S, Petitjean J, Corbet S, Freymuth F. Detection of the new human coronavirus HKU1: a report of 6 cases. Clin Infect Dis 2006; 42(5): 634-639.
6. Rohde G, Drosten C, Borg I, et al. [Detection of respiratory viruses - how, when, where and why?] Pneumologie 2009; 63(1): 14-22.
7. Woo PC, Lau SK, Chu CM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005; 79(2): 884-895.
8. McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci USA 1967; 57(4): 933-940.
9. van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med 2004; 10(4): 368-373.
10. Sloots TP, Whiley DM, Lambert SB, Nissen MD. Emerging respiratory agents: new viruses for old diseases? J Clin Virol 2008; 42(3): 233-243.
11. Woo PC, Lau SK, Huang Y, Tsoi HW, Chan KH, Yuen KY. Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia. Arch Virol 2005; 150(11): 2299-2311.
12. Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD, Mackay IM. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol 2006; 35(1): 99-102.
13. Gerna G, Percivalle E, Sarasini A, et al. Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. J Clin Virol 2007; 38(3): 244-250.
14. Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Coronavirus HKU1 infection in the United States. Emerg Infect Dis 2006; 12(5): 775-779.
15. Lau SK, Woo PC, Yip CC, et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 2006; 44(6): 2063-2071.
16. Woo PC, Lau SK, Tsoi HW, et al. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis 2005; 192(11): 1898-1907.
17. Cilla G, Onate E, Perez-Yarza EG, Montes M, Vicente D, Perez-Trallero E. Viruses in community-acquired pneumonia in children aged less than 3 years old: high rate of viral coinfection. J Med Virol 2008; 80(10): 1843-1849.
18. Garbino J, Crespo S, Aubert JD, et al. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (non-SARS)-related human coronavirus infection. Clin Infect Dis 2006; 43(8): 1009-1015.
19. Guarner J, Shieh WJ, Dawson J, et al. Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. Am J Clin Pathol 2000; 114(2): 227-233.
20. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003; 348(9): 867-868.
21. Afessa B, Peters SG. Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med 2006; 27(3): 297-309.